Exicure, Inc. (XCUR) stock
XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.08+0.01 (+0.93%)
Close on Nov 17, 2026Market cap $7.07MP/E –Yield –
Exicure total assets
Total assets on the balance sheet at the end of each period.
Exicure's total assets was $11.40M at Jun 30, 2026. For fiscal 2025 it was $14.04M, down 6.7% from the year before. The highest annual figure on record is $115.26M in fiscal 2019.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.04M | -6.7% |
| FY2024 | Dec 31, 2024 | $15.06M | +30.0% |
| FY2023 | Dec 31, 2023 | $11.58M | -50.4% |
| FY2022 | Dec 31, 2022 | $23.33M | -64.0% |
| FY2021 | Dec 31, 2021 | $64.87M | -35.4% |
| FY2020 | Dec 31, 2020 | $100.44M | -12.9% |
| FY2019 | Dec 31, 2019 | $115.26M | +300.8% |
| FY2018 | Dec 31, 2018 | $28.76M | -0.8% |
| FY2017 | Dec 31, 2017 | $28.99M | +40.9% |
| FY2016 | Dec 31, 2016 | $20.58M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.40M | -39.2% |
| Q1 FY2026 | Mar 31, 2026 | $12.76M | -38.3% |
| Q4 FY2025 | Dec 31, 2025 | $14.04M | -6.7% |
| Q3 FY2025 | Sep 30, 2025 | $15.27M | +43.6% |
| Q2 FY2025 | Jun 30, 2025 | $18.74M | +75.3% |
| Q1 FY2025 | Mar 31, 2025 | $20.68M | +93.1% |
| Q4 FY2024 | Dec 31, 2024 | $15.06M | +30.0% |
| Q3 FY2024 | Sep 30, 2024 | $10.63M | -17.9% |
| Q2 FY2024 | Jun 30, 2024 | $10.69M | -39.1% |
| Q1 FY2024 | Mar 31, 2024 | $10.71M | -55.3% |
| Q4 FY2023 | Dec 31, 2023 | $11.58M | -50.4% |
| Q3 FY2023 | Sep 30, 2023 | $12.95M | -55.3% |
| Q2 FY2023 | Jun 30, 2023 | $17.56M | -52.5% |
| Q1 FY2023 | Mar 31, 2023 | $23.94M | -42.9% |
| Q4 FY2022 | Dec 31, 2022 | $23.33M | -64.0% |
| Q3 FY2022 | Sep 30, 2022 | $28.94M | -62.8% |
| Q2 FY2022 | Jun 30, 2022 | $36.96M | -50.4% |
| Q1 FY2022 | Mar 31, 2022 | $41.90M | -52.4% |
| Q4 FY2021 | Dec 31, 2021 | $64.87M | -35.4% |
| Q3 FY2021 | Sep 30, 2021 | $77.90M | -30.0% |
| Q2 FY2021 | Jun 30, 2021 | $74.47M | -22.5% |
| Q1 FY2021 | Mar 31, 2021 | $87.95M | -16.7% |
| Q4 FY2020 | Dec 31, 2020 | $100.44M | -12.9% |
| Q3 FY2020 | Sep 30, 2020 | $111.28M | +50.8% |
| Q2 FY2020 | Jun 30, 2020 | $96.12M | +374.5% |
| Q1 FY2020 | Mar 31, 2020 | $105.53M | +319.0% |
| Q4 FY2019 | Dec 31, 2019 | $115.26M | +300.8% |
| Q3 FY2019 | Sep 30, 2019 | $73.81M | +107.8% |
| Q2 FY2019 | Jun 30, 2019 | $20.26M | +4.7% |
| Q1 FY2019 | Mar 31, 2019 | $25.18M | +3.4% |
| Q4 FY2018 | Dec 31, 2018 | $28.76M | -0.8% |
| Q3 FY2018 | Sep 30, 2018 | $35.53M | +40.0% |
| Q2 FY2018 | Jun 30, 2018 | $19.34M | +1251874.1% |
| Q1 FY2018 | Mar 31, 2018 | $24.35M | +338479.2% |
| Q4 FY2017 | Dec 31, 2017 | $28.99M | +40.9% |
| Q3 FY2017 | Sep 30, 2017 | $25.37M | – |
| Q2 FY2017 | Aug 31, 2017 | $1.55K | – |
| Q1 FY2017 | May 31, 2017 | $7.19K | – |
| Q4 FY2016 | Dec 31, 2016 | $20.58M | – |
See a number that looks wrong?